Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mortimer

Showing results (231-240 of 262) with videos related to

Pageof 27
Sort By:
Microcirculation (New York, N.Y. : 1994)|June 12, 2010
Lymphatic dysfunction, not aplasia, underlies Milroy diseaseRussell H Mellor, Charlotte E Hubert, Anthony W B Stanton, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 10, 2010
Measurement of lymph node function from the extraction of immunoglobulin in lymphJ Charlotte Fowler, Tom Bennett Britton, Elena Provenzano, et al.
Circulation Research|February 16, 2013
Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedemaKristiana Gordon, Dörte Schulte, Glen Brice, et al.
Implementation Science : IS|November 12, 2010
Improving the care for people with acute low-back pain by allied health professionals (the ALIGN trial): A cluster randomised trial protocolJoanne E McKenzie, Denise A O'Connor, Matthew J Page, et al.
JCI Insight|September 12, 2023
Erythematous capillary-lymphatic malformations mimicking blood vascular anomaliesRené Hägerling, Malou Van Zanten, Rose Yinghan Behncke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapyR Kim, M Kwon, M An, et al.
JCI Insight|August 18, 2017
VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformationsRené Hägerling, Dominik Drees, Aaron Scherzinger, et al.
Trials|February 15, 2022
Improving adherence to acute low back pain guideline recommendations with chiropractors and physiotherapists: the ALIGN cluster randomised controlled trialSimon D French, Denise A O'Connor, Sally E Green, et al.
The Oncologist|April 10, 2023
AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)Koung Jin Suh, Min-Hee Ryu, Dae Young Zang, et al.
Implementation Science : IS|August 21, 2013
Evidence-based care of older people with suspected cognitive impairment in general practice: protocol for the IRIS cluster randomised trialJoanne E McKenzie, Simon D French, Denise A O'Connor, et al.
Pageof 27

Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
Microcirculation (New York, N.Y. : 1994)|June 12, 2010
Lymphatic dysfunction, not aplasia, underlies Milroy diseaseRussell H Mellor, Charlotte E Hubert, Anthony W B Stanton, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 10, 2010
Measurement of lymph node function from the extraction of immunoglobulin in lymphJ Charlotte Fowler, Tom Bennett Britton, Elena Provenzano, et al.
Circulation Research|February 16, 2013
Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedemaKristiana Gordon, Dörte Schulte, Glen Brice, et al.
Implementation Science : IS|November 12, 2010
Improving the care for people with acute low-back pain by allied health professionals (the ALIGN trial): A cluster randomised trial protocolJoanne E McKenzie, Denise A O'Connor, Matthew J Page, et al.
JCI Insight|September 12, 2023
Erythematous capillary-lymphatic malformations mimicking blood vascular anomaliesRené Hägerling, Malou Van Zanten, Rose Yinghan Behncke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapyR Kim, M Kwon, M An, et al.
JCI Insight|August 18, 2017
VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformationsRené Hägerling, Dominik Drees, Aaron Scherzinger, et al.
Trials|February 15, 2022
Improving adherence to acute low back pain guideline recommendations with chiropractors and physiotherapists: the ALIGN cluster randomised controlled trialSimon D French, Denise A O'Connor, Sally E Green, et al.
The Oncologist|April 10, 2023
AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)Koung Jin Suh, Min-Hee Ryu, Dae Young Zang, et al.
Implementation Science : IS|August 21, 2013
Evidence-based care of older people with suspected cognitive impairment in general practice: protocol for the IRIS cluster randomised trialJoanne E McKenzie, Simon D French, Denise A O'Connor, et al.
Pageof 27